{"id":950740,"date":"2026-04-13T08:06:29","date_gmt":"2026-04-13T12:06:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/"},"modified":"2026-04-13T08:06:29","modified_gmt":"2026-04-13T12:06:29","slug":"stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/","title":{"rendered":"Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio"},"content":{"rendered":"<div class=\"mw_release\">\n<p>Portage, Michigan, April  13, 2026  (GLOBE NEWSWIRE) &#8212; Stryker (NYSE:SYK), a global leader in medical technologies, announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat calcified peripheral arterial disease.<\/p>\n<p>The acquisition will strengthen Stryker\u2019s Peripheral Vascular (PV) portfolio by adding revascularization technology. Once cleared for use in applicable markets, the product will complement Stryker\u2019s existing PV offerings and support the company\u2019s strategy to expand its presence in arterial disease treatment.<\/p>\n<p>\u201cThis acquisition represents an important step in advancing our vision to build a comprehensive peripheral vascular platform and address significant unmet clinical needs,\u201d said Kevin Lobo, Chair and CEO, Stryker. \u201cCombining this innovation with Stryker\u2019s scale and clinical expertise, we believe we can help expand treatment options for physicians and improve care for patients with calcified peripheral arterial disease.\u201d<\/p>\n<p>AVS\u2019 technology is designed to use pulsed CO\u2082-generated pressure waves uniformly delivered through an IVL balloon catheter, to fracture calcium and optimize luminal gain. The platform is designed to enhance catheter deliverability, treatment speed and therapy efficiency.<\/p>\n<p>IVL is a fast-growing technology in cardiovascular intervention and is used to treat calcified peripheral and coronary lesions. It is expected to experience strong growth as physicians adopt IVL-based calcium modification in complex procedures.<\/p>\n<p>This transaction is subject to customary closing conditions. Stryker and AVS will continue to operate as separate entities and proceed with business as usual until the transaction closes.<\/p>\n<p>\n        <b>About Stryker<\/b>\n      <\/p>\n<p>Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at <a href=\"https:\/\/www.stryker.com\/\" rel=\"nofollow\" target=\"_blank\">www.stryker.com.<\/a><\/p>\n<p>\n        <b>About <\/b><br \/>\n        <b>Amplitude Vascular Systems (<\/b><br \/>\n        <b>AVS)<\/b>\n      <\/p>\n<p>Amplitude Vascular Systems (AVS) is a medical device company based in Boston, Mass., focused on treating severely calcified arterial disease. AVS is backed by global investors including BioStar Capital, Cue Growth Partners, and others. It was founded in 2017 by Hitinder Gurm, M.D., Interventional Cardiologist and Chief Clinical Officer at the University of Michigan, and Robert Chisena, Ph.D., Chief Technical Officer at AVS. More information is available at <u>www.avspulse.com<\/u>.<\/p>\n<p>\n        <b>Contacts<\/b>\n      <\/p>\n<p>\n        <b>For investor inquiries:<\/b><br \/>\n        <br \/>Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or jason.beach@stryker.com<\/p>\n<p>\n        <b>For media inquiries:<\/b><br \/>\n        <br \/>Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4ODEyMiM3NTMwOTIwIzIwMDgzMjg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDI0M2FkMjktOTYxOS00ZWI1LWI0MTItZTVjYTFjY2U3OWRmLTEwMTk5MDEtMjAyNi0wNC0xMy1lbg==\/tiny\/Stryker-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Portage, Michigan, April 13, 2026 (GLOBE NEWSWIRE) &#8212; Stryker (NYSE:SYK), a global leader in medical technologies, announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat calcified peripheral arterial disease. The acquisition will strengthen Stryker\u2019s Peripheral Vascular (PV) portfolio by adding revascularization technology. Once cleared for use in applicable markets, the product will complement Stryker\u2019s existing PV offerings and support the company\u2019s strategy to expand its presence in arterial disease treatment. \u201cThis acquisition represents an important step in advancing our vision to build a comprehensive peripheral vascular platform and address significant unmet clinical needs,\u201d said Kevin Lobo, Chair and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-950740","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Portage, Michigan, April 13, 2026 (GLOBE NEWSWIRE) &#8212; Stryker (NYSE:SYK), a global leader in medical technologies, announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat calcified peripheral arterial disease. The acquisition will strengthen Stryker\u2019s Peripheral Vascular (PV) portfolio by adding revascularization technology. Once cleared for use in applicable markets, the product will complement Stryker\u2019s existing PV offerings and support the company\u2019s strategy to expand its presence in arterial disease treatment. \u201cThis acquisition represents an important step in advancing our vision to build a comprehensive peripheral vascular platform and address significant unmet clinical needs,\u201d said Kevin Lobo, Chair and &hellip; Continue reading &quot;Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-13T12:06:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4ODEyMiM3NTMwOTIwIzIwMDgzMjg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio\",\"datePublished\":\"2026-04-13T12:06:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\\\/\"},\"wordCount\":448,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4ODEyMiM3NTMwOTIwIzIwMDgzMjg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\\\/\",\"name\":\"Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4ODEyMiM3NTMwOTIwIzIwMDgzMjg=\",\"datePublished\":\"2026-04-13T12:06:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4ODEyMiM3NTMwOTIwIzIwMDgzMjg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4ODEyMiM3NTMwOTIwIzIwMDgzMjg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/","og_locale":"en_US","og_type":"article","og_title":"Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio - Market Newsdesk","og_description":"Portage, Michigan, April 13, 2026 (GLOBE NEWSWIRE) &#8212; Stryker (NYSE:SYK), a global leader in medical technologies, announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology company developing a next-generation intravascular lithotripsy (IVL) platform designed to treat calcified peripheral arterial disease. The acquisition will strengthen Stryker\u2019s Peripheral Vascular (PV) portfolio by adding revascularization technology. Once cleared for use in applicable markets, the product will complement Stryker\u2019s existing PV offerings and support the company\u2019s strategy to expand its presence in arterial disease treatment. \u201cThis acquisition represents an important step in advancing our vision to build a comprehensive peripheral vascular platform and address significant unmet clinical needs,\u201d said Kevin Lobo, Chair and &hellip; Continue reading \"Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-13T12:06:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4ODEyMiM3NTMwOTIwIzIwMDgzMjg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio","datePublished":"2026-04-13T12:06:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/"},"wordCount":448,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4ODEyMiM3NTMwOTIwIzIwMDgzMjg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/","name":"Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4ODEyMiM3NTMwOTIwIzIwMDgzMjg=","datePublished":"2026-04-13T12:06:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4ODEyMiM3NTMwOTIwIzIwMDgzMjg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4ODEyMiM3NTMwOTIwIzIwMDgzMjg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/stryker-signs-definitive-agreement-to-acquire-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=950740"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950740\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=950740"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=950740"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=950740"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}